TXNStandard Analysis
Texas Instruments (TXN) Analysis
Semiconductors|NASDAQ|US
Published July 30, 2026 · 0 views
This report is auto-generated by an AI stock research platform for informational purposes only. The content is for general information and research reference, and does not constitute financial advice. Data may lag or be incomplete. Always conduct your own research and consult qualified professionals before making any financial decisions.
# [Qiltrack AI] Texas Instruments Inc (TXN) 3-Minute Overview
## 🎯 30-Second Key Takeaways
> **💡 One-Sentence Summary**
>
> Texas Instruments is the old-school but extremely profitable king of analog chips—think the "Intel inside" for everything from factory robots to your car's touchscreen—that prints cash but is currently priced like a growth stock.
> **📍 Basic Profile**
>
> Market Cap **$247.8 billion** · Semiconductors · NASDAQ · Price **$271.30**
---
> **⚡ 3 Things You Should Know**
>
> 1. 💰 **Cash Machine with a Catch**: Gross margins of 58% and net margins of 31% are elite—almost every dollar of revenue is highly profitable. But the payout ratio is 99.96%, meaning nearly all earnings go to dividends, leaving little for reinvestment.
>
> 2. 📉 **Growth Has Stalled**: Revenue has shrunk at an average of -4% per year over the last 3 years. The recent 22.8% quarterly revenue pop is a recovery from a deep trough, not a new trend. Earnings per share have declined -16.6% annually over the same period.
>
> 3. 🏷️ **Expensive Relative to Its Own History**: At 42x trailing earnings, TXN trades well above its 5-year average PE. The market is betting this cyclical recovery turns into sustained growth, but a 99% payout ratio leaves little margin for error if the recovery fizzles.
---
> **🎯 Quick Health Check**
>
> | Dimension | Rating | Details |
> |-----------|--------|---------|
> | Profitability | Strong💪 | Net margin 31.1%, top tier in semiconductors |
> | Growth Rate | Slow🐢 | 3-year revenue CAGR -4.1%, recent quarter +22.8% (recovery bounce) |
> | Financial Health | Healthy💚 | Debt/equity 86%, but current ratio 4.86—very liquid |
> | Valuation | Pricey | PE 42x vs 5-year average ~25x; market pricing in a strong rebound |
---
## 📋 2-Minute Deep Dive
#### 📊 How Does This Company Make Money?
**Business Model in One Sentence:** Designs and manufactures analog chips and embedded processors sold to industrial, automotive, and personal electronics customers, making money through high-margin, long-lifecycle product sales.
**Revenue Breakdown:**
| Business | Share | Trend | Comment |
|----------|-------|-------|---------|
| Analog | ~70% | ↑ | Core cash cow, high margins, long product cycles |
| Embedded Processing | ~20% | → | Steady but lower margins than analog |
| Other | ~10% | → | Includes DLP products and custom ASICs |
**Profitability Metrics:**
| Metric | Value | Ranking | Interpretation |
|--------|-------|---------|----------------|
| Gross Margin | 58.33% | Top 10% | Excellent—analog chips have sticky pricing and long lifecycles |
| Net Margin | 31.11% | Top 5% | Exceptional cost control; one of the most profitable semi companies |
| ROE | 35.77% | Excellent>20% | Outstanding capital efficiency |
---
#### 📈 How's the Growth?
**Growth Assessment:** Slowing / Cyclical Recovery
| Metric | Latest Q (YoY) | vs Last Year | Trend |
|--------|----------------|--------------|-------|
| Revenue Growth | +22.8% | -4.1% (3yr CAGR) | Recovering from a deep downturn |
| Profit Growth | +44.6% (est.) | -16.6% (3yr CAGR) | Earnings recovering faster than revenue due to operating leverage |
**Growth Quality:**
> The recent +22.8% revenue surge is a cyclical recovery, not a new growth trend. The semiconductor industry went through a severe inventory correction in 2023-2024, and TXN is now bouncing back. The real question is whether this recovery turns into sustainable growth—the 3-year revenue decline of -4% annually suggests the underlying trend is still shaky.
---
#### 💰 Financial Health Check
**One Sentence:** Financially rock-solid—sitting on a fortress balance sheet with tons of cash, low debt, and enough liquidity to weather any storm.
| Metric | Value | Safe Zone | Assessment |
|--------|-------|-----------|------------|
| Debt Ratio | 86.3% | <60% safe | ⚠️High—but this is mostly long-term debt at low rates |
| Current Ratio | 4.86 | >1.5 healthy | ✅Very Safe—massive liquidity buffer |
| Cash Flow | $9.02/share | >0 | ✅Positive—healthy cash generation |
---
#### 🏷️ Is It Expensive Now?
**Price Position (based on 52-week range):**
- 52-Week Low: $152.73
- 52-Week High: $334.03
- Current: $271.30, In the middle (58.6% position)
| Position Range | Cheap Zone | Fair Zone | Pricey Zone |
|----------------|------------|-----------|-------------|
| Criteria | 0-33% | 33-66% | 66-100% |
| **Current** | | ●(58.6%) | |
**Valuation Comparison:**
| Comparison | Current | Reference | Assessment |
|------------|---------|-----------|------------|
| vs Own History | PE 42.1x | 5-year avg ~25x | High by ~68% |
| vs Peers | PE 42.1x | Semi industry avg ~30x | High by ~40% |
**What the Current Valuation is Betting On:**
> At 42x earnings, the market is betting that the cyclical recovery is real and sustainable—that TXN can return to double-digit revenue growth and maintain its 30%+ net margins. It's also betting that the company's massive investment in its own manufacturing capacity (300mm wafer fabs) will pay off with higher margins. If the recovery stalls or margins compress, the stock could drop 30-40%.
---
#### 📰 Any Recent News?
| Date | Event | Impact |
|------|-------|--------|
| Jul 22, 2026 | Q2 earnings beat: revenue $5.46B (+22.8% YoY), EPS $2.14 vs $1.95 expected | Positive—strong beat, but stock fell 5% (buy the rumor, sell the news) |
| Jul 22, 2026 | Q3 revenue guidance of $5.9B, 4.9% above analyst expectations | Positive—guidance suggests recovery is accelerating |
| Jul 2026 | Multiple analyst upgrades to Strong Buy | Positive—Wall Street turning bullish on the recovery story |
| May-Jun 2026 | Insider selling: CFO Lizardi sold ~$10M worth of shares | Negative—insiders taking profits after the big run-up |
---
## 📊 3-Minute Complete Analysis
#### I. Detailed Financial Data
**Profitability Trends:**
| Metric | Latest Year | Prior Year | 2 Years Ago | 3-Year Trend |
|--------|-------------|------------|-------------|--------------|
| Gross Margin | ~58% | ~57% | ~59% | → Stable |
| Net Margin | ~31% | ~28% | ~32% | → Stable with slight dip |
| ROE | 35.8% | ~30% | ~35% | ↑ Recovering |
**Growth Trends:**
| Metric | Latest Q (YoY) | Last Year | 2 Years Ago | 3-Year Trend |
|--------|----------------|-----------|-------------|--------------|
| Revenue Growth | +22.8% | -12% | -15% | ↑ Cyclical recovery |
| Profit Growth | +44.6% (est.) | -25% | -30% | ↑ Sharp recovery |
| EPS Growth | +44% (est.) | -28% | -32% | ↑ Recovering from trough |
---
#### II. Earnings Track Record
**Last 4 Quarters vs Expectations:**
| Quarter | EPS Expected | EPS Actual | Surprise |
|---------|--------------|------------|----------|
| Q2 2026 | $1.95 | $2.14 | +9.5% Beat 😀 |
| Q1 2026 | $1.38 | $1.68 | +21.6% Beat 😀 |
| Q4 2025 | $1.31 | $1.27 | -2.8% Miss 😟 |
| Q3 2025 | $1.50 | $1.48 | -1.6% Miss 😟 |
**Earnings Trend Interpretation:** The company has shifted from 2 consecutive misses to 2 strong beats, signaling the cyclical recovery is real. The magnitude of the beats (9.5% and 21.6%) is impressive—management is under-promising and over-delivering.
---
#### III. What the Market Thinks
**Analyst Ratings:**
| Rating | Count | Percentage |
|--------|-------|------------|
| Strong Buy/Buy | 19 firms | 43% |
| Hold | 22 firms | 50% |
| Sell | 3 firms | 7% |
**Target Price:** No specific target price available in data.
**vs Current Price:** N/A
**Insider Activity:** Net selling of ~$10M+ in past 3 months
> Multiple top executives (CFO, board members) have sold shares after the stock's 65% year-to-date rally. While some selling is normal for diversification, the volume and timing suggest insiders see the current price as full or overvalued.
---
#### IV. Key Risk Alerts
**3 Risks to Watch:**
1. **Valuation Risk:** PE of 42x is 68% above historical average. If the recovery disappoints, the stock could correct 30-40% as multiple compression kicks in.
2. **Dividend Sustainability:** With a 99.96% payout ratio, TXN is paying out virtually all earnings as dividends. Any earnings decline would force a dividend cut or halt—a major negative for income investors.
3. **Cyclical Relapse:** The semiconductor industry is notoriously cyclical. If the global economy weakens or inventory builds up again, TXN's revenue could fall back into negative territory, crushing the growth narrative that supports the high valuation.
---
## 🎬 Summary & Next Steps
> **📝 Three-Sentence Summary**
>
> **What it is:** A world-class analog chip manufacturer with exceptional profitability and a fortress balance sheet.
>
> **Key strength:** 31% net margins and 36% ROE—this is one of the most capital-efficient businesses in the entire market.
>
> **Key risk:** At 42x earnings, you're paying a huge premium for a cyclical recovery that may already be priced in, with insiders selling and a 99% payout ratio leaving no buffer.
---
> **🔍 Want to Learn More?**
>
> • Want to know if this company has a strong moat? → Try【Buffett Mode】for deeper analysis
>
> • Want to check for hidden landmines? → Try【Muddy Mode】for risk screening
>
> • Is this a growth stock? Want to calculate if it's worth the bet? → Try【Musk Mode】for analysis